Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Simple Resolution 167
116th Congress(2019-2020)
Recognizing the rise of cardiovascular disease as the world's leading cause of preventable death and disability and as the global public health crisis of our generation and supporting the recognition of February 2019 as "American Heart Month".
Introduced
Introduced
Introduced in House on Feb 28, 2019
Overview
Text
Introduced in House 
Feb 28, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Feb 28, 2019)
Feb 28, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. RES. 167 (Introduced-in-House)


116th CONGRESS
1st Session
H. RES. 167


Recognizing the rise of cardiovascular disease as the world’s leading cause of preventable death and disability and as the global public health crisis of our generation and supporting the recognition of February 2019 as “American Heart Month”.

IN THE HOUSE OF REPRESENTATIVES

February 28, 2019

Mr. Smith of New Jersey (for himself and Mrs. Beatty) submitted the following resolution; which was referred to the Committee on Foreign Affairs, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

RESOLUTION

Recognizing the rise of cardiovascular disease as the world’s leading cause of preventable death and disability and as the global public health crisis of our generation and supporting the recognition of February 2019 as “American Heart Month”.

    Whereas the World Health Organization estimates that in 2016, 17.9 million people died from cardiovascular diseases (CVDs) globally;

    Whereas, of these deaths, 85 percent were due to heart attacks and strokes and over three-quarters of CVD deaths occur in low- and middle-income countries;

    Whereas CVDs result in tremendous health care costs and lost productivity and, if not addressed, the United States alone will spend over 1 trillion dollars by 2035 on costs relating to CVD;

    Whereas the heavy burden of death and disability from CVDs can be decreased through changes in behavior linked to major risk factors, including reduced tobacco use and salt consumption and improvements in access to medical treatment and services;

    Whereas essential quality-assured medicines and technologies are critical components to address the global burden of CVDs; and

    Whereas United States leadership and support has strengthened surveillance, enhanced workforce capacity, and provided valuable technical exchanges in the area of CVD: Now, therefore, be it

Resolved,

That the House of Representatives—

(1) supports recognition of American Heart Month to bring awareness to the cardiovascular disease (CVD) public health crisis in the United States and abroad;

(2) affirms that the key to overcoming CVDs is prevention and early detection and treatment to reduce long-term disability and mortality;

(3) urges the deployment of United States technical expertise on CVDs in support of developing capacities and strengthening of the health care systems of other countries;

(4) values the quality of life for CVD patients around the world and their reintegration to society; and

(5) calls on the Department of State, the United States Agency for International Development, and the Centers for Disease Control and Prevention, to—

(A) comprehensively examine the impact of CVDs on health and development in United States priority assistance countries; and

(B) develop a coordinated strategy that improves the effectiveness and impact of United States-financed global health programming by integrating CVD into existing programs.